Intellia Therapeutics, Inc.
NTLA- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001652130
In the last 90 days, Intellia Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 329 institutions reported holding it in 13F filings for Q2 2026, worth $2.43B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q3 2022
Institutional positions in Intellia Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 321
- +22 vs. Q2 2022
- Shares held
- 68.0M
- +432.0K (+0.6%) vs. Q2 2022
- Total value
- $3.81B
- +$362.7M (+10.5%) vs. Q2 2022
- New holders
- 48
- 112 more added
- Sold out
- 26
- 99 more reduced
2 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NTLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 329 | $2.43B |
| Q1 2026 | 306 | $1.41B |
| Q4 2025 | 295 | $938.9M |
| Q3 2025 | 284 | $1.80B |
| Q2 2025 | 283 | $933.8M |
| Q1 2025 | 296 | $720.3M |
| Q4 2024 | 295 | $1.16B |
| Q3 2024 | 284 | $1.92B |
| Q2 2024 | 291 | $2.02B |
| Q1 2024 | 284 | $2.51B |
| Q4 2023 | 293 | $2.60B |
| Q3 2023 | 286 | $2.53B |
| Q2 2023 | 292 | $3.19B |
| Q1 2023 | 291 | $2.93B |
| Q4 2022 | 304 | $2.72B |
| Q3 2022 | 321 | $3.81B |
| Q2 2022 | 301 | $3.44B |
| Q1 2022 | 348 | $4.71B |
| Q4 2021 | 372 | $7.60B |
| Q3 2021 | 366 | $8.34B |
| Q2 2021 | 337 | $10.0B |
| Q1 2021 | 261 | $5.07B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Intellia Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Northern Trust Corp | 704,774 | $39.4M | 0.01% | +717+0.1% | Added |
| Pictet Asset Management SA | 766,162 | $42.9M | 0.06% | +130,312+20.5% | Added |
| Charles Schwab Investment Management Inc | 771,975 | $43.2M | 0.02% | +58,530+8.2% | Added |
| Dimensional Fund Advisors LP | 910,108 | $50.9M | 0.02% | −8,790−1.0% | Reduced |
| Goldman Sachs Group Inc | 981,755 | $54.9M | 0.02% | +133,572+15.7% | Added |
| Avidity Partners Management LP | 999,100 | $55.9M | 1.22% | −126,094−11.2% | Reduced |
| Chevy Chase Trust Holdings, Inc. | 1,137,475 | $63.7M | 0.27% | +101,170+9.8% | Added |
| Himension Fund | 1,191,193 | $66.7M | 7.07% | −25,147−2.1% | Reduced |
| Geode Capital Management, LLC | 1,374,128 | $76.9M | 0.01% | +81,540+6.3% | Added |
| Alliancebernstein L.P. | 1,422,201 | $79.6M | 0.04% | −282,450−16.6% | Reduced |
| Federated Hermes, Inc. | 1,514,600 | $84.8M | 0.25% | +96,300+6.8% | Added |
| Morgan Stanley | 1,530,551 | $85.7M | 0.01% | +294,357+23.8% | Added |
| Price T Rowe Associates Inc | 1,737,260 | $97.2M | 0.02% | −310,071−15.1% | Reduced |
| Viking Global Investors LPSuperinvestorViking Global Investors | 1,889,067 | $105.7M | 0.49% | −339,316−15.2% | Reduced |
| FMR LLC | 2,626,753 | $147.0M | 0.02% | −678,653−20.5% | Reduced |
| State Street Corp | 2,687,719 | $150.4M | 0.01% | −456,092−14.5% | Reduced |
| Nikko Asset Management Americas, Inc. | 2,963,928 | $164.5M | 2.10% | +182,792+6.6% | Added |
| Sumitomo Mitsui Trust Holdings, Inc. | 2,963,928 | $165.9M | 0.14% | +182,792+6.6% | Added |
| BlackRock Inc. | 6,128,140 | $342.9M | 0.01% | +240,741+4.1% | Added |
| Vanguard Group Inc | 6,617,323 | $370.3M | 0.01% | +108,041+1.7% | Added |
| ARK Investment Management LLCSuperinvestorARK Invest | 9,657,052 | $540.4M | 3.77% | +142,472+1.5% | Added |
| Lord, Abbett & Co. LLC | 0 | $0 | 0.00% | −375,399−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −119,600−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −99,379−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −96,118−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −68,437−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −38,600−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −26,901−100.0% | Sold out |
| ETF Managers Group, LLC | 0 | $0 | 0.00% | −18,663−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −15,473−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −14,653−100.0% | Sold out |
| EFG Asset Management (North America) Corp. | 0 | $0 | 0.00% | −13,316−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −6,822−100.0% | Sold out |
| Delphia (USA) Inc. | 0 | $0 | 0.00% | −4,238−100.0% | Sold out |
| 1623 Capital LLC | 0 | $0 | 0.00% | −4,117−100.0% | Sold out |
| DuPont Capital Management Corp | 0 | $0 | 0.00% | −2,228−100.0% | Sold out |
| Twin Tree Management, LP | 0 | $0 | 0.00% | −828−100.0% | Sold out |
| Banque Cantonale Vaudoise | 0 | $0 | 0.00% | −415−100.0% | Sold out |
| Concord Wealth Partners | 0 | $0 | 0.00% | −366−100.0% | Sold out |
| Prospera Financial Services Inc | 0 | $0 | 0.00% | −351−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −270−100.0% | Sold out |
| Patriot Financial Group Insurance Agency, LLC | 0 | $0 | 0.00% | −157−100.0% | Sold out |
| Umb Bank N A | 0 | $0 | 0.00% | −79−100.0% | Sold out |
| Cyrus J. Lawrence, LLC | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| Washington Trust Advisors, Inc. | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Cordasco Financial Network | – | – | – | – | Not filed |
| Private Capital Group, LLC | – | – | – | – | Not filed |